The advantages and disadvantages of a 'herbal' medicine in a patient with diabetes mellitus: a case reportWOOD, D. M; ATHWAL, S; PANAHLOO, A et al.Diabetic medicine. 2004, Vol 21, Num 6, pp 625-627, issn 0742-3071, 3 p.Article

TRAITEMENT DU DIABETE INSIPIDE PAR LE CHLORPROPAMIDE CHEZ DES SUJETS ATTEINTS DE XANTHOMATOSEARAPOVA SD.1972; PROBL. ENDOKRINOL.; S.S.S.R.; DA. 1972; VOL. 18; NO 3; PP. 58-59; BIBL. 3REF.Article

EXPERIENCES RELATIVES AU TRAITEMENT DU DIABETE INSIPIDE PAR LE CHLORPROPAMIDEKAJLAKOV AM.1975; KLIN. MED.; S.S.S.R.; DA. 1975; VOL. 53; NO 4; PP. 91-93; ABS. ANGL.; BIBL. 16 REF.Article

Chlorpropamide toxicity with survival despite 27-day hypoglycemiaCIECHANOWSKI, K; BOROWIAK, K. S; POTOCKA, B. A et al.Journal of toxicology. Clinical toxicology. 1999, Vol 37, Num 7, pp 869-871, issn 0731-3810Article

ZUR POLYMORPHIE ORALER ANTIDIABETIKA. I. CHLORPROPAMID. = LE POLYMORPHISME DES ANTIDIABETIQUES ORAUX. I. LE CHLORPROPAMIDEBURGER A.1975; SCI. PHARM.; AUTR.; DA. 1975; VOL. 43; NO 3; PP. 152-161; BIBL. 13 REF.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC DETERMINATION OF CHLORPROPAMIDE IN TABLET FORMULATIONS = DETERMINATION DU CHLORPROPAMIDE PAR CHROMATOGRAPHIE LIQUIDE SOUS PRESSION ELEVEE DANS LES FORMULES DE COMPRIMESMOLINS D; WONG CK; COHEN DM et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 1; PP. 123-124; BIBL. 10REF.Article

Crystallization and polymorphic transitions of chlorpropamide in aqueous 2-hydroxybutyl-β-cyclodextrin solutionISHIGURO, Takako; HIRAYAMA, Fumitoshi; IOHARA, Daisuke et al.European journal of pharmaceutical sciences. 2010, Vol 39, Num 4, pp 248-255, issn 0928-0987, 8 p.Article

Comparative bioavailability study with two chlorpropamide tablet formulations in healthy volunteersAPARECIDA DA SILVA, Marcia; MENDES, Fabiana D; DE OLIVEIRA, Rogério Antonio et al.Arzneimittel-Forschung. 2007, Vol 57, Num 9, pp 591-598, issn 0004-4172, 8 p.Article

Kinetic analysis of chlorpropamide dissolution from solid dispersionsBARZEGAR-JALALI, Mohammad; DASTMALCHI, Siavoush.Drug development and industrial pharmacy. 2007, Vol 33, Num 1, pp 63-70, issn 0363-9045, 8 p.Article

Effect of pressure up to 5.5 GPa on dry powder samples of chlorpropamide form-ABOLDYREVA, Elena V; DMITRIEV, Vladimir; HANCOCK, Bruno C et al.International journal of pharmaceutics. 2006, Vol 327, Num 1-2, pp 51-57, issn 0378-5173, 7 p.Article

TERAPIA DEL DIABETE INSIPIDO CON CLORPROPAMIDE = LE TRAITEMENT DU DIABETE INSIPIDE PAR LE CHLORPROPAMIDEDE SANCTIS C; STELLA L; MUSSA F et al.1974; MINERVA PEDIATR.; ITAL.; DA. 1974; VOL. 26; NO 38; PP. 1924-1929; ABS. ANGL.; BIBL. 21REF.Article

HYPOGLYCEAMIA DUE TO ERRONEOUS DRUG INGESTION = HYPOGLYCEMIE PAR INGESTION MEDICAMENTEUSE ERRONEESTOCKS AE; MARTIN FIR.1972; MED. J. AUSTRAL.; AUSTRAL.; DA. 1972; VOL. 1; NO 24; PP. 1256-1258; BIBL. 12REF.Serial Issue

EXPERIENCE PERSONNELLE DU CHLORPROPAMIDE DANS LE TRAITEMENT DES SYNDROMES POLYURO-POLYDIPSIQUESLINQUETTE M; FOSSATI P; LEFEBVRE J et al.1972; LILLE MED.; FR.; DA. 1972; VOL. 17; NO 9; PP. 1216-1225; BIBL. 1P.1/2Serial Issue

Effect of Nigerian meals on the Pharmacokinetics of chlorpropamide in type II diabetic patientsBAKARE-ODUNOLA, M. T; MUSTAPHA, A; ABDU AGUYE, I et al.European journal of drug metabolism and pharmacokinetics. 2008, Vol 33, Num 1, pp 31-35, issn 0378-7966, 5 p.Article

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro : chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphismSHON, Ji-Hong; YOON, Young-Ran; KIM, Min-Jung et al.British journal of clinical pharmacology. 2005, Vol 59, Num 5, pp 552-563, issn 0306-5251, 12 p.Article

N¹-alkyl-substituted derivatives of chlorpropamide as inhibitors of aldehyde dehydrogenaseNAGASAWA, H. T; ELBERLING, J. A; DEMASTER, E. G et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 6, pp 1335-1340, issn 0022-2623, 6 p.Article

PHASE EQUILIBRIA AND STABILITY CHARACTERISTICS OF CHLORPROPAMIDE-UREA SOLID DISPERSIONS.FORD JL; RUBINSTEIN MH.1977; J. PHARM. PHARMACOL.; G.B.; DA. 1977; VOL. 29; NO 4; PP. 209-211; BIBL. 14 REF.Article

FATAL VASCULAR COMPLICATIONS IN DIABETIC PATIENTS TREATED BY DIET, SULFONYLUREAS AND INSULIN. A RETROSPECTIVE STUDY = COMPLICATIONS VASCULAIRES MORTELLES CHEZ LES PATIENTS DIABETIQUES TRAITES PAR LE REGIME, LA SULFONUREE ET L'INSULINE. ETUDE RETROSPECTIVEFIDEL J; NELKEN L.1974; ISRAEL J. MED. SCI.; ISRAEL; DA. 1974; VOL. 10; NO 7; PP. 702-706; BIBL. 16REF.Article

PHARMACOKINETICS AND BIOTRANSFORMATION OF CHLORPROPAMIDE IN MAN = PHARMACOCINETIQUE ET BIOTRANSFORMATION DU CHLORPROPAMIDE CHEZ L'HOMMETAYLOR JA.1972; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1972; VOL. 13; NO 5, PART I; PP. 710-718; BIBL. 1P.Serial Issue

A PARTIAL DEFECT IN ANTIDIURETIC HORMONE SECRETION-CHLORPROPAMIDE RESPONSE = REPONSE A LA CHLORPROPAMIDE DANS UN DEFICIT PARTIEL DE LA SECRETION D'HORMONE ANTIDIURETIQUEMALONE JI; VALLET HL; BONGIOVANNI AM et al.1972; J. PEDIATR.; U.S.A.; DA. 1972; VOL. 81; NO 1; PP. 92-95; BIBL. 8 REF.Article

PMR spectrometric analysis of chlorpropamideAL-BADR, A. A.Pharmazie. 1983, Vol 38, Num 8, issn 0031-7144, 568Article

GLYBURIDE1976; MED. LETTER DRUGS THERAPEUT.; U.S.A.; DA. 1976; VOL. 18; NO 13; PP. 54-55Article

CHLORPROPAMIDE-INDUCED HYPONATRAEMIAPEAK HJ; HORNIBLON A.1975; MED. J. AUSTRAL.; AUSTRAL.; DA. 1975; VOL. 2; NO 23; PP. 867; BIBL. 2 REF.Article

LONGITUDINAL STUDY OF UNTREATED CHEMICAL DIABETES = ETUDE LONGITUDINALE DU DIABETE CHIMIQUE NON TRAITELOGIE AW; STOWERS JM; DINGWALL FORDYCE I et al.1974; BRIT. MED. J.; G.B.; DA. 1974; NO 5945; PP. 630-632; BIBL. 37REF.Article

MECHANISM OF CHLORPROPAMIDE ACTION IN PATIENTS WITH DIABETES INSIPIDUS = MECANISME DE L'ACTION DE LA CHLORPROPAMIDE CHEZ DES MALADES PORTEURS D'UN DIABETE INSIPIDEMURASE T; YOSHIDA S.1973; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1973; VOL. 36; NO 1; PP. 174-177; BIBL. 9REF.Article